Global Postpartum Hemorrhage Treatment Devices Market to reach USD 926.1 million in 2023
©
According to a new market report published by Transparency Market Research “Postpartum Hemorrhage (PPH) Treatment Devices Market - Global Industry Analysis, Size, Growth, Trends and Forecast, 2015 - 2023”, the global postpartum hemorrhage treatment devices market was valued at USD 604.4 million in 2014 and is estimated to reach USD 926.1 million in 2023, expanding at a CAGR of 4.9% from 2015 to 2023.According to the World Health Organization (WHO), postpartum hemorrhage (PPH) is the principal cause of maternal mortality, accounting for more than 30% of all maternal deaths in developed as well as developing countries. This condition can be defined as blood loss in excess of 500 mL after vaginal delivery or more than 1,000 mL after cesarean delivery. Moreover, if such blood loss occurs within 24 hours of delivery, it is categorized as early or primary PPH. If such blood loss occurs after 24 hours of delivery, it is termed as late or secondary PPH. The organization also stated that more than 14 million women suffer from PPH globally each year, of these 150,000 women die annually.
Browse Full Report: http://www.transparencymarketresearch.com/pressrelease/postpartum-hemorrhage-treatment-devices-market.htm
Major factors likely to boost the growth of the market are high prevalence of PPH in various countries, growing number of educational and training initiatives by governments, and escalating risk factors related to PPH. However, lack of product awareness in the emerging economies and low acceptance of unconventional preventive devices would hamper the growth of the postpartum hemorrhage treatment devices market during the forecast period.
Non-pneumatic anti-shock garment (NASG), Uniject prefilled injection system, and uterine balloon tamponade collectively form the postpartum hemorrhage treatment devices market. The uterine balloon tamponade segment has been sub-segmented into Foley catheters, condom catheters, and others. Uterine balloon tamponade was the largest segment of the PPH treatment devices market, accounting for approximately 46.3% share in 2014. The segment is expected to maintain its leadership position during the forecast period. Factors such as ultra-low cost, easy availability, and high effectiveness have been attributed to the largest share of the uterine balloon tamponade segment. In addition, several public health organizations such as the International Confederation of Midwives (ICM), the American College of Obstetricians and Gynecologists, and the World Health Organization (WHO) recognize UBT devices as an ultra-affordable medical alternative that could significantly help in the management of PPH in resource-poor health care settings where pharmaceutical and surgical interventions are not readily available.
Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6164
Key organizations studied and profiled in this study include Cook Medical, Inc., Teleflex Incorporated, C. R. Bard, Inc., 3rd Stone Design, Inc., Bactiguard AB, Program for Appropriate Technology in Health (PATH), Utah Medical Products, Inc., and ZOEX NIASG. These players also collaborate with health care facilities, maternal clinics, and various other organizations through long-term agreements in order to provide innovative preventive PPH treatment devices. This, in turn, helps them to strengthen their market position and subsequently experience rapid growth.
Browse the full Postpartum Hemorrhage (PPH) Treatment Devices Market (Product Type: NASG, Uniject Prefilled Injection System, Uterine Balloon Tamponade (Foley Catheters, Condom Catheters and Others) - Global Industry Analysis, Size, Growth, Trends and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/postpartum-hemorrhage-treatment-devices-market.html
The global postpartum hemorrhage treatment devices market has been segmented into the following categories:
Postpartum Hemorrhage (PPH) Treatment Devices Market, by Products
Non-pneumatic Anti-shock Garment (NASG)
Uniject Prefilled Injection System
Uterine Balloon Tamponade
Foley Catheters
Condom Catheters
Others
Postpartum Hemorrhage (PPH) Treatment Devices Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
Rest of Europe
Asia Pacific
Japan
China
Rest of Asia Pacific
Latin America (LATAM)
Middle East & North Africa (MENA)
Rest of the World
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Browse Full Report: http://www.transparencymarketresearch.com/pressrelease/postpartum-hemorrhage-treatment-devices-market.htm
Major factors likely to boost the growth of the market are high prevalence of PPH in various countries, growing number of educational and training initiatives by governments, and escalating risk factors related to PPH. However, lack of product awareness in the emerging economies and low acceptance of unconventional preventive devices would hamper the growth of the postpartum hemorrhage treatment devices market during the forecast period.
Non-pneumatic anti-shock garment (NASG), Uniject prefilled injection system, and uterine balloon tamponade collectively form the postpartum hemorrhage treatment devices market. The uterine balloon tamponade segment has been sub-segmented into Foley catheters, condom catheters, and others. Uterine balloon tamponade was the largest segment of the PPH treatment devices market, accounting for approximately 46.3% share in 2014. The segment is expected to maintain its leadership position during the forecast period. Factors such as ultra-low cost, easy availability, and high effectiveness have been attributed to the largest share of the uterine balloon tamponade segment. In addition, several public health organizations such as the International Confederation of Midwives (ICM), the American College of Obstetricians and Gynecologists, and the World Health Organization (WHO) recognize UBT devices as an ultra-affordable medical alternative that could significantly help in the management of PPH in resource-poor health care settings where pharmaceutical and surgical interventions are not readily available.
Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6164
Key organizations studied and profiled in this study include Cook Medical, Inc., Teleflex Incorporated, C. R. Bard, Inc., 3rd Stone Design, Inc., Bactiguard AB, Program for Appropriate Technology in Health (PATH), Utah Medical Products, Inc., and ZOEX NIASG. These players also collaborate with health care facilities, maternal clinics, and various other organizations through long-term agreements in order to provide innovative preventive PPH treatment devices. This, in turn, helps them to strengthen their market position and subsequently experience rapid growth.
Browse the full Postpartum Hemorrhage (PPH) Treatment Devices Market (Product Type: NASG, Uniject Prefilled Injection System, Uterine Balloon Tamponade (Foley Catheters, Condom Catheters and Others) - Global Industry Analysis, Size, Growth, Trends and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/postpartum-hemorrhage-treatment-devices-market.html
The global postpartum hemorrhage treatment devices market has been segmented into the following categories:
Postpartum Hemorrhage (PPH) Treatment Devices Market, by Products
Non-pneumatic Anti-shock Garment (NASG)
Uniject Prefilled Injection System
Uterine Balloon Tamponade
Foley Catheters
Condom Catheters
Others
Postpartum Hemorrhage (PPH) Treatment Devices Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
Rest of Europe
Asia Pacific
Japan
China
Rest of Asia Pacific
Latin America (LATAM)
Middle East & North Africa (MENA)
Rest of the World
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/